U-Neuron Biomedical (ROCO:6973) FCF Margin % : -134.55% (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is U-Neuron Biomedical FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. U-Neuron Biomedical's Free Cash Flow for the six months ended in Dec. 2023 was NT$-20.21 Mil. U-Neuron Biomedical's Revenue for the six months ended in Dec. 2023 was NT$15.02 Mil. Therefore, U-Neuron Biomedical's FCF Margin % for the quarter that ended in Dec. 2023 was -134.55%.

As of today, U-Neuron Biomedical's current FCF Yield % is -3.88%.

The historical rank and industry rank for U-Neuron Biomedical's FCF Margin % or its related term are showing as below:

ROCO:6973' s FCF Margin % Range Over the Past 10 Years
Min: -205.75 Med: -148.38 Max: -8.84
Current: -205.75

During the past 4 years, the highest FCF Margin % of U-Neuron Biomedical was -8.84%. The lowest was -205.75%. And the median was -148.38%.

ROCO:6973's FCF Margin % is ranked worse than
54.97% of 1046 companies
in the Biotechnology industry
Industry Median: -144.01 vs ROCO:6973: -205.75

U-Neuron Biomedical FCF Margin % Historical Data

The historical data trend for U-Neuron Biomedical's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U-Neuron Biomedical FCF Margin % Chart

U-Neuron Biomedical Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

FCF Margin %

-8.84

-148.38

-205.75

U-Neuron Biomedical Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	-	-134.50	-166.71	-294.88	-134.55

Competitive Comparison of U-Neuron Biomedical's FCF Margin %

For the Biotechnology subindustry, U-Neuron Biomedical's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

U-Neuron Biomedical's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, U-Neuron Biomedical's FCF Margin % distribution charts can be found below:

* The bar in red indicates where U-Neuron Biomedical's FCF Margin % falls into.

U-Neuron Biomedical FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

U-Neuron Biomedical's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-55.599	/	27.023
	=	-205.75 %

U-Neuron Biomedical's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-20.214	/	15.023
	=	-134.55 %

U-Neuron Biomedical FCF Margin % Related Terms

Thank you for viewing the detailed overview of U-Neuron Biomedical's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

U-Neuron Biomedical (ROCO:6973) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » U-Neuron Biomedical Inc (ROCO:6973) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

https://en.u-neuron.com

U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.

U-Neuron Biomedical (ROCO:6973) Headlines

No Headlines